CoChat

Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis

Zhang, Xin-Lin, Zhu, Li, Wei, Zhong-Hai, Zhu, Qing-Qing, Qiao, Jian-Zhong, Dai, Qing, Huang, Wei, Li, Xiao-Hong, Xie, Jun, Kang, Li-Na, Wang, Lian, Xu, Biao · 2016 · Annals of Internal Medicine

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Theoretically, the everolimus-eluting bioresorbable vascular scaffold (BVS) could eliminate stent thrombosis and improve outcomes in patients having percutaneous coronary intervention. PURPOSE: To estimate the incidence of stent thrombosis after BVS implantation and to compare the efficacy and safety of BVSs versus everolimus-eluting metallic stents (EESs) in adults having percutaneous coronary intervention. DATA SOURCES: PubMed, EMBASE, Cochrane Central Register of Controlled Trials, conference proceedings, and relevant Web sites from inception through 20 January 2016. STUDY SELECTION: 6 randomized, controlled trials and 38 observational studies, each involving at least 40 patients with BVS implantation. DATA EXTRACTION: Two reviewers independently extracted study data and evaluated study risk of bias. DATA SYNTHESIS: The pooled incidence of definite or probable stent thrombosis after BVS implantation was 1.5 events per 100 patient-years (PYs) (95% CI, 1.2 to 2.0 events per 100 PYs) (126 events during 8508 PYs). Six randomized trials that directly compared BVSs with EESs showed a non-statistically significant increased risk for stent thrombosis (odds ratio [OR], 2.05 [CI, 0.95 to 4.43]; P = 0.067) and myocardial infarction (OR, 1.38 [CI, 0.98 to 1.95]; P = 0.064) with BVSs. The 6 observational studies that compared BVSs with EESs showed increased risk for stent thrombosis (OR, 2.32 [CI, 1.06 to 5.07]; P = 0.035) and myocardial infarction (OR, 2.09 [CI, 1.23 to 3.55]; P = 0.007) with BVSs. The relative rates of all-cause and cardiac death, revascularization, and target lesion failure were similar for BVSs and EESs. LIMITATION: Scarce comparative data, no published data from large trials with long-term follow-up, and limited quality and incomplete reporting of observational studies. CONCLUSION: Compared with EESs, BVSs do not eliminate and might increase risks for stent thrombosis and myocardial infarction in adults having percutaneous coronary intervention. Results of large trials with long-term follow-up are critically needed to establish the safety or at least the noninferiority of BVSs compared with EESs. PRIMARY FUNDING SOURCE: None.

Overview

Integrity signals

Registry

Crossref · 10.7326/m16-0006

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 62 references

Research works printed but not linked: 4

  1. Onuma Y, 2014, Eur Heart J, 35, 982
  2. Azzalini L, 2015, J Invasive Cardiol, 27, 85
  3. Robaei D, 2015, J Invasive Cardiol
  4. Romero M, 2015, Eur Heart J, 36, 649

Cited by

Metadata

Authors
Zhang, X.-L., Zhu, L., Wei, Z.-H., Zhu, Q.-Q., Qiao, J.-Z., Dai, Q., Huang, W., Li, X.-H., Xie, J., Kang, L.-N., Wang, L., & Xu, B.
Affiliations
  • From Affiliated Drum Tower Hospital and Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
  • Nanjing General Hospital of Nanjing Military Command (CN)
Venue
Annals of Internal Medicine
Published
2016-06-07
Volume
164
Issue
11
Pages
752-763
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2418707371
Cited by
31
References
62
Citations by year
2024: 3 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 6 · 2016: 9
FWCI
1.32
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
bioresorbable vascular scaffolds, everolimus-eluting stent, metallic stents, percutaneous coronary intervention, stent thrombosis, myocardial infarction, target lesion failure, revascularization, coronary artery disease, drug-eluting stents, long-term outcomes, cardiovascular mortality, all-cause mortality
MeSH terms
Everolimus, Cardiovascular Agents, Cause of Death, Coronary Artery Disease, Humans, Myocardial Infarction, Postoperative Complications, Thrombosis, Absorbable Implants, Tissue Scaffolds, Drug-Eluting Stents, Comparative Effectiveness Research, Percutaneous Coronary Intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.